Related Experiment Video
Updated: Jun 4, 2026

Visualizing the DNA Damage Response in Purkinje Cells Using Cerebellar Organotypic Cultures
Published on: December 27, 2024
HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents
D Palmieri1, T Valentino, D D'Angelo
1Dipartimento di Biologia e Patologia Cellulare e Molecolare c/o Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Facoltà di Medicina e Chirurgia di Napoli, Università degli Studi di Napoli Federico II, Naples, Italy.
Abstract:
DNA-damaging therapies represent a keystone in cancer treatment. Unfortunately, many tumors often relapse because of a group of cancer cells, which are resistant to conventional therapies. High-mobility group A (HMGA) proteins has a key role in cell transformation, and their overexpression is a common feature of human malignant neoplasias, representing a poor prognostic index often correlated to anti-cancer drug resistance. Our previous results demonstrated that HMGA1 is a substrate of ataxia-telangiectasia mutated (ATM), the main cellular sensor of genotoxic stress. Here we also report thatHMGA2, the other member of the HMGA family, is a novel substrate of ATM. Interestingly, we found that HMGA proteins positively regulate ATM gene expression. Moreover, induction of ATM kinase activity by DNA-damaging agents enhances HMGA-dependent transcriptional activation of ATM promoter, suggesting that ATM expression is modulated by a DNA-damage- and HMGA-dependent positive feedback loop. Finally, inhibition of HMGA expression in mouse embryonic fibroblasts and in cancer cells strongly reduces ATM protein levels, impairing the cellular DNA-damage response and enhancing the sensitivity to DNA-damaging agents. These findings indicate this novel HMGA-ATM pathway as a new potential target to improve the effectiveness of conventional anti-neoplastic treatments on the genotoxic-drug resistant cancer cells.
Insights
High-mobility group A (HMGA) proteins regulate ATM gene expression, impacting DNA damage response. Inhibiting HMGA enhances cancer cells
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- DNA-damaging therapies are crucial for cancer treatment but face resistance from specific cancer cell populations.
- High-mobility group A (HMGA) proteins are implicated in cell transformation and are overexpressed in many cancers, correlating with poor prognosis and drug resistance.
- Ataxia-telangiectasia mutated (ATM) is the primary cellular sensor of genotoxic stress.
Purpose of the Study:
- To investigate the relationship between HMGA proteins and ATM in the context of DNA damage response.
- To explore the role of HMGA proteins in regulating ATM gene expression and its impact on cancer drug resistance.
Main Methods:
- Investigated HMGA1 and HMGA2 as substrates of ATM.
- Analyzed HMGA proteins' effect on ATM gene expression using promoter activity assays.
- Studied the impact of HMGA inhibition on ATM levels, DNA damage response, and sensitivity to DNA-damaging agents in cell models.
Main Results:
- HMGA2 was identified as a novel substrate of ATM.
- HMGA proteins positively regulate ATM gene expression, forming a positive feedback loop modulated by DNA damage and ATM activity.
- Inhibition of HMGA expression reduced ATM protein levels, impaired DNA damage response, and increased sensitivity to DNA-damaging agents.
Conclusions:
- A novel HMGA-ATM pathway has been identified, crucial for regulating the DNA damage response.
- This pathway represents a potential therapeutic target to overcome resistance to genotoxic anti-cancer drugs.
- Targeting HMGA could enhance the efficacy of conventional cancer treatments in resistant tumors.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
